Ethanolamine oleate sclerotherapy for hydroceles and spermatoceles: a survey of 158 patients with ultrasound followup.

Abstract

Sclerotherapy with 5% ethanolamine oleate was used to treat 102 hydroceles in 100 patients and 63 spermatoceles in 58 patients. Scrotal ultrasound examination was performed before the sclerotherapy and at each followup visit. Of the hydroceles 98% were cured completely and 68% were cured after only 1 sclerosant instillation, while 60% of the spermatoceles resolved completely and 33% partially, with 7% failures. No hydroceles recurred during an average followup of 43 months, whereas spermatocele recurred in 4 patients more than 1 year after successful treatment, with a mean followup of 46 months. Approximately half of the patients experienced pain after treatment, 3 had infection and 2 had hematoma. No changes in the structure or size of the testicles were found by ultrasound during followup. Ethanolamine oleate sclerotherapy is a safe, effective and economical form of outpatient therapy that can be recommended as primary treatment for hydroceles in adults and as an alternative to surgery for spermatoceles with 1 to 3 cysts in elderly men in whom fertility is not important.

• Authors: T L Tammela, P A Hellström, S I Mattila, P J Ottelin, L J Malinen, H P Mäkäräinen
• Journal: The Journal of urology (J Urol) Vol. 147 Issue 6 Pg. 1551-3 (Jun 1992) ISSN: 0022-5347 [Print] United States
• PMID: 1593687 (Publication Type: Journal Article)

Chemical References

• Oleic Acids
• Sclerosing Solutions
• ethanolamine oleate

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Follow-Up Studies
• Humans
• Male
• Middle Aged
• Oleic Acids (therapeutic use)
• Recurrence
• Sclerosing Solutions (therapeutic use)
• Sclerotherapy
• Spermatocele (diagnostic imaging, therapy)
• Testicular Hydrocele (diagnostic imaging, therapy)
• Ultrasonography